Mechanism of Action and Clinical Implications of Statins

Pharmacodynamic Effects and Clinical Benefits

Statins reduce hepatic cholesterol synthesis, leading to upregulation of LDL receptors and enhanced clearance of LDL particles from the bloodstream, resulting in a reduction of LDL-cholesterol levels by approximately 20-35% at standard doses, with some variation between different statins 1
The American Heart Association recommends statin therapy for patients at increased cardiovascular risk, as it is associated with reduced risk of cardiovascular events and mortality, with the clinical benefit appearing to be proportional to the degree of LDL-cholesterol reduction 2, 1, 3
A 1 mM drop in LDL-cholesterol has been associated with a 21% drop in major vascular events, according to the Proceedings of the Nutrition Society 2

The combination of statins with dietary modifications that reduce saturated fat intake may have additive effects on LDL-cholesterol reduction, though evidence in humans is limited, as suggested by the Proceedings of the Nutrition Society 4, 5

Statins also reduce levels of total cholesterol and, to a lesser extent, triglycerides, in addition to their LDL-cholesterol lowering effects, as reported in JAMA 1

By inhibiting HMG-CoA reductase, statins decrease hepatic cholesterol synthesis, creating a cholesterol-depleted state in liver cells, which triggers upregulation of LDL receptor expression on hepatocyte cell surfaces via the sterol regulatory element binding transcription factor 2 (SREBP2) pathway, according to the European Heart Journal 6
Statins work complementarily with ezetimibe and PCSK9 inhibitors, increasing LDL receptor availability and enhancing LDL clearance, as reported by the European Heart Journal 6

The combination of statins with ezetimibe and PCSK9 inhibitors leads to increased LDL receptor availability and enhanced LDL clearance, resulting in reduced LDL-cholesterol levels, as stated by the European Heart Journal 6